TABLE 1.
Treatments | Medium | Cell lysate | Cholesterol effluxa | ApoAI-mediated effluxb |
---|---|---|---|---|
dpm | dpm | % | % | |
Without apoAI | ||||
Control | 104 ± 9 | 38362 ± 4072 | 0.27 ± 0.04 | |
ApoE3 | 138 ± 6 | 39427 ± 3610 | 0.35 ± 0.05 | |
Reelin | 114 ± 16 | 39310 ± 4258 | 0.29 ± 0.04 | |
With apoAI | ||||
Control | 261 ± 17 | 39574 ± 5038 | 0.66 ± 0.06 | 0.39 ± 0.05 |
ApoE3 | 937 ± 71c | 39886 ± 3077 | 2.35 ± 0.29c | 2.00 ± 0.24c |
Reelin | 640 ± 103c | 37854 ± 4908 | 1.69 ± 0.22c | 1.40 ± 0.21c |
a Cholesterol efflux was expressed as the percentage of radioactivity in the medium compared to the total radioactivity (cell lysate plus medium).
b ApoAI-mediated cholesterol efflux was calculated as the difference between the values obtained in the presence or absence of ApoAI in the medium. Values represent the mean ± S.E. of four independent experiments.
c p < 0.05 compared to controls.